ADVM Shares Outstanding History
Below is a table of the ADVM shares outstanding history going back to 7/31/2014:

Date ADVM Shares Outstanding
7/31/201420.78M
8/31/201422.26M
10/31/201422.47M
2/28/201525.22M
4/30/201525.53M
7/31/201525.68M
10/31/201525.76M
2/29/201626.86M
4/29/201627.13M
7/29/201641.35M
10/31/201641.72M
2/28/201742.06M
4/30/201742.87M
7/31/201743.29M
10/31/201745.04M
2/28/201862.17M
4/30/201862.27M
7/31/201862.69M
10/31/201862.87M
2/28/201963.20M
4/30/201963.43M
7/31/201964.46M
8/8/201917.72M
10/31/201964.59M
2/28/202079.68M
8/3/202080.66M
10/30/202097.48M
2/22/202197.80M
4/29/202197.93M
7/30/202198.13M
10/29/202198.15M

Also see: ADVM Market Cap History
ADVM YTD Return
ADVM Historical Shares Outstanding:
+23.88% CAGR
ADVM Historical Shares Outstanding: +23.88% CAGR

Mouse over chart for data details
7/31/2014 ...10/29/2021
Adverum Biotechnologies is a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases. ADVM-022 is a single, in-office intravitreal injection gene therapy. ADVM-022 is being developed for the treatment of patients with chronic retinal diseases who respond to anti-vascular endothelial growth factor therapy, including wet age-related macular degeneration and diabetic macular edema. ADVM-022 utilizes a proprietary vector capsid, AAV.7m8, carrying an aflibercept coding sequence under the control of a proprietary expression cassette. We show 31 historical shares outstanding datapoints in our coverage of ADVM's shares outstanding history.

Understanding the changing numbers of ADVM shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ADVM versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ADVM by allowing them to research ADVM shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree ADVM Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Adverum Biotechnologies (ADVM) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ADXS Shares Outstanding History
ADYX Shares Outstanding History
AEMD Shares Outstanding History
AERI Shares Outstanding History
AEZS Shares Outstanding History
AFIB Shares Outstanding History
AGEN Shares Outstanding History
AGIO Shares Outstanding History
AGL Shares Outstanding History
AGLE Shares Outstanding History
More Healthcare companies »

 

ADVM Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.